Search research articles
Contact Us
Filters
Showing results (1-10 of 170) with videos related to
Page
of 17
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 21, 2013
Metabolic syndrome and hepatitis C infection--brothers in arms
Jerzy Jaroszewicz, Robert Flisiak
Przeglad Epidemiologiczny
|
June 10, 2008
[Treatment recommendations of chronic hepatitis B. Did the world escape us?]
Robert Flisiak, Jerzy Jaroszewicz
Polish Archives of Internal Medicine
|
March 1, 2021
Neurologic manifestations of COVID-19. Authors' reply
Monika Adamczyk-Sowa, Jerzy Jaroszewicz
Przeglad Epidemiologiczny
|
June 27, 2016
Hepatitis E virus infection--a new threat for Europe
Tadeusz Wojciech Łapiński, Jerzy Jaroszewicz
World Journal of Gastroenterology
|
October 30, 2007
Specifically targeted antiviral therapy for hepatitis C virus
Anna Parfieniuk, Jerzy Jaroszewicz, Robert Flisiak
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|
January 14, 2012
[Cytokeratin 18 as an indicator of the activity of liver disease]
Magdalena Luto, Jerzy Jaroszewicz, Robert Flisiak
Expert Opinion on Biological Therapy
|
May 3, 2018
siRNA drug development against hepatitis B virus infection
Robert Flisiak, Jerzy Jaroszewicz, Mariusz Łucejko
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
November 4, 2008
Serum prohepcidin reflects the degree of liver function impairment in liver cirrhosis
Jerzy Jaroszewicz, Magdalena Rogalska, Robert Flisiak
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 4, 2013
A pill for HCV - myth or foreseeable future?
Jerzy Jaroszewicz, Robert Flisiak, Geoffrey Dusheiko
Clinical and Experimental Hepatology
|
September 1, 2017
Surgical treatment of liver tumors - own experience and literature review
Aliaksandr Tarasik, Jerzy Jaroszewicz, Marcin Januszkiewicz
Page
of 17
Search research articles
Search
Showing results (1-10 of 170) with videos related to
Sort By:
Page
of 17
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 21, 2013
Metabolic syndrome and hepatitis C infection--brothers in arms
Jerzy Jaroszewicz, Robert Flisiak
Przeglad Epidemiologiczny
|
June 10, 2008
[Treatment recommendations of chronic hepatitis B. Did the world escape us?]
Robert Flisiak, Jerzy Jaroszewicz
Polish Archives of Internal Medicine
|
March 1, 2021
Neurologic manifestations of COVID-19. Authors' reply
Monika Adamczyk-Sowa, Jerzy Jaroszewicz
Przeglad Epidemiologiczny
|
June 27, 2016
Hepatitis E virus infection--a new threat for Europe
Tadeusz Wojciech Łapiński, Jerzy Jaroszewicz
World Journal of Gastroenterology
|
October 30, 2007
Specifically targeted antiviral therapy for hepatitis C virus
Anna Parfieniuk, Jerzy Jaroszewicz, Robert Flisiak
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|
January 14, 2012
[Cytokeratin 18 as an indicator of the activity of liver disease]
Magdalena Luto, Jerzy Jaroszewicz, Robert Flisiak
Expert Opinion on Biological Therapy
|
May 3, 2018
siRNA drug development against hepatitis B virus infection
Robert Flisiak, Jerzy Jaroszewicz, Mariusz Łucejko
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
November 4, 2008
Serum prohepcidin reflects the degree of liver function impairment in liver cirrhosis
Jerzy Jaroszewicz, Magdalena Rogalska, Robert Flisiak
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 4, 2013
A pill for HCV - myth or foreseeable future?
Jerzy Jaroszewicz, Robert Flisiak, Geoffrey Dusheiko
Clinical and Experimental Hepatology
|
September 1, 2017
Surgical treatment of liver tumors - own experience and literature review
Aliaksandr Tarasik, Jerzy Jaroszewicz, Marcin Januszkiewicz
Page
of 17